The 20 Best Hereditary Neuroblastoma Doctors Near Me in Pittsburgh, PA

Jenny Ruiz, MD, specializes in pediatric hematology oncology and is board certified in pediatric hematology-oncology and pediatrics by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh, Pediatric Hematology/Oncology and is affiliated with UPMC Magee-Womens Hospital. Dr. Ruiz completed her fellowship at Children's Hospital of Philadelphia, residency at Columbia University, and medical education at Columbia University College of Physicians and Surgeons. Dr. Ruiz is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her clinical expertise encompasses Leukemia, Acute Lymphoblastic Leukemia (ALL), Ewing Sarcoma, and Osteosarcoma. Dr. Ruiz is board certified in American Board Of Pediatrics and American Board Of Pediatrics. Dr. Ruiz is currently accepting new patients.

Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.

Anwaar Saeed, MD, is an Associate Professor of Medicine and the Chief of the Gastrointestinal (GI) Medical Oncology Program at the University of Pittsburgh, University of Pittsburgh Medical Center (UPMC), and UPMC Hillman Cancer Center. She also serves as the Vice Chair of the Colorectal Cancer Committee of the NSABP Foundation. Her research efforts are focused on immune modulatory approaches in patients with gastric & esophageal cancer, colon cancer and hepatocellular carcinoma as well as chemoprevention/ immunoprevention in the high-risk GI population. She has published more than 150 peer reviewed papers, posters and book chapters, and have led more than 40 clinical trials, focused on various immune modulatory regimens including but not limited to immune checkpoint inhibitor combinations with chemotherapy, other checkpoint inhibitors, antibody drug conjugates, bi-specific T cell engagers (BiTE), angiogenesis inhibitors, as well as immunotherapy combinations with regional approaches like stereotactic radiosurgery and intensity-modulated radiation therapy. She currently leads several investigator-initiated trials focused on novel targeted immunotherapy combinations including the ongoing phase I/II CAMILLA multicohort study looking at Cabozantinib plus Durvalumab with or without Tremelimumab in GI malignancies. Results from phase I/II part of the CAMILLA led to the development of the currently ongoing global pivotal trial, STELLAR 303, in patients with previously treated microsatellite stable colorectal cancer. She is also the study chair for a soon to open SWOG/intergroup NCI national trial (S2303) testing a novel chemo-immunotherapy regimen in patients with advanced gastric & esophageal adenocarcinoma. Dr. Saeed is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Stomach Cancer, Familial Colorectal Cancer, and Gamma Knife Radiosurgery. Dr. Saeed is board certified in American Board Of Internal Medicine. Dr. Saeed is currently accepting new patients.

Jennifer Osborn, MD, specializes in hematology oncology and is board-certified in medical oncology by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center at UPMC Passavant-McCandless and UPMC Hillman Cancer Center at UPMC Passavant-Cranberry and is affiliated with UPMC Passavant and UPMC Magee-Womens Hospital. Dr. Osborn received her medical degree from The Ohio State University College of Medicine and completed her residency and fellowship at the University of Pittsburgh School of Medicine. Dr. Osborn is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer. Dr. Osborn is board certified in American Board Of Internal Medicine. Dr. Osborn is currently accepting new patients.

Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, and Clear Cell Sarcoma.

Helena Levitt, MD, is board-certified in endocrinology, diabetes, and metabolism by the American Board of Internal Medicine. She practices at UPMC Center for Diabetes and Endocrinology and is affiliated with UPMC Williamsport, UPMC Muncy, UPMC Presbyterian, and UPMC Magee-Womens Hospital. Dr. Levitt completed her medical degree and fellowship at the University of Pittsburgh School of Medicine and residency at the University of Virginia School of Medicine. Dr. Levitt is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Multiple Endocrine Neoplasia, Multiple Endocrine Neoplasia Type 1, Postmenopausal Osteoporosis, and Osteoporosis. Dr. Levitt is board certified in American Board Of Internal Medicine. Dr. Levitt is currently accepting new patients.